About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Molecular Secrets of Bile Duct Cancers Exposed

by Kathy Jones on November 4, 2013 at 8:55 PM
Font : A-A+

 Molecular Secrets of Bile Duct Cancers Exposed

Researchers from National Cancer Centre Singapore, Duke-NUS Graduate Medical School Singapore, Fundeni Clinical Institute (Romania) and Koen Kaen University (Thailand) revealed that they have made an important breakthrough in mapping the molecular basis of bile duct cancer or cholangiocarcinoma, a rare but highly lethal form of liver cancer.

1.The team, led by Professors Teh Bin Tean, Patrick Tan, Steve Rozen, Irinel Popescu and Vajaraphongsa Bhudhisawasdi, used advanced DNA sequencing technologies to map the complete repertoire of human genes disrupted in cholangiocarcinoma.

Advertisement

2.The team's findings may lead to new cholangiocarcinoma treatments, and have shed light on some of the oldest questions in cancer research. The group is also affiliated with the Genome Institute of Singapore and the Cancer Science Institute in Singapore. This work was published online today in the scientific journal Nature Genetics.

3.Cholangiocarcinoma (CCA), is a cancer involving uncontrolled growth of the bile ducts, the part of the liver that drains bile into the intestine. In most countries, CCA is considered a rare cancer, but the incidence of CCA is rising worldwide and in certain countries such as the North East of Thailand and neighbouring Laos, CCA is already widespread due to patients in this region being exposed to liver flukes. Other potential causes of CCA include bile duct inflammation, congenital cysts, hepatitis, and the presence of liver stones. Patients diagnosed with CCA have a dismal prognosis as the disease is considered incurable, with a 5-year survival rate of 5%.
Advertisement

New Potential Avenues for Treatment

4.By studying CCAs from Singapore, Thailand and Romania, the team identified several genes that were repeatedly disrupted in order for CCA to develop. Importantly, the cellular pathways controlled by these genes have suggested new potential avenues to treat CCA. One such gene identified, BAP1, participates in the unpacking of DNA, and drugs targeting this process (called "chromatin modifier drugs") are being developed. Prof Teh said "While further research needs to be done, this may pave the way for identifying which bile-duct cancer patients may benefit from chromatin-modifier drugs."

5.Findings from the study have also deepened our basic understanding of how cancer develops. Prof Rozen said "A poorly-understood question in cancer research is whether different carcinogens, applied to the same cancer type, will cause disruptions in the same sets of genes, or if different carcinogens will cause different type of genes to be disrupted".

6.The team reasoned that CCAs could be used to answer these questions, as these cancers are caused by different carcinogenic exposure in different parts of the world. They found that while CCAs from Thailand, Singapore and Romania appeared very similar under the conventional microscope, at the molecular level they were in fact very different. This provides one of the first key pieces of evidence that different types of carcinogen exposures, although acting on the same type of tissue, are associated with disruptions in different sets of genes. Such findings have practical applications as well. Prof Tan said "Based on these results, it may be possible to investigate a patient's cancer and by looking at the types of disrupted genes, infer what caused the cancer." Such information would have major implications for cancer prevention efforts.

7.This most recent work is the latest in a series of high-profile papers from the Singapore team applying genomic analysis to cancers prevalent in Asia. In August, the same team reported their findings on a specific type of urinary tract cancer prevalent in Taiwan, which was caused by a carcinogen found in certain herbal remedies.

Invitation to join leading International Cancer Genome Consortium

8.The success of the team has not gone unnoticed by the international community. In October, the team of Professors Teh, Tan and Rozen was invited to join the International Cancer Genome Consortium (ICGC), a multi-national consortium composed of the world's leading scientists in cancer genomics, which aims to analyze over 50 different types of cancer. The Singapore team will take the lead in organizing the ICGC CCA sequencing program. "The ICGC Executive committee welcomes the participation of Singapore with great enthusiasm. The cholangiocarcinoma project will fit an important gap in the ICGC list of cancer types and the Singapore team has a track record of proven expertise and experience in this field", said Dr Tom Hudson, Chair of ICGC Executive Committee.

9.To-date, the Singapore team has raised funds from charities including a million dollar donation from a patient, and research institutions in Singapore to support the ICGC effort. Prof Teh concluded "This will be first time that Singapore has participated in such a large international cancer consortium. We will do our utmost to make this international effort a success but our greatest hope is that our findings will ultimately benefit cancer patients worldwide"



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Sensory Processing Disorder (SPD)
First Dose of COVID-19 Vaccines May Improve Mental Health
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Patent Ductus Arteriosus Cancer Bile Duct Cancer Sclerosing Cholangitis Ampullary Cancer Common Lifestyle Habits that Cause Diseases Health Benefits of Dandelion Plant Alagille Syndrome Immune Checkpoint Inhibitors for Cancer Treatment Non-Communicable Diseases 

Recommended Reading
Gallbladder Cancer
Gallbladder cancer is a cancer that starts in the walls of the gallbladder. It is a rare form of ......
Nausea and Vomiting
Nausea and vomiting is a common problem that could be caused by conditions affecting the digestive ....
Interstitial Cystitis
Interstitial cystistis is an umbrella term where a pathology cannot be defined but the patient ......
Alagille Syndrome
Alagille syndrome is a rare genetic disorder that is caused by hereditary or spontaneous mutations i...
Ampullary Cancer
Ampullary cancer is a rare cancer of the ampulla of Vater that connects the common bile duct and pan...
Bile Duct Cancer
Bile duct cancer occurs either within the liver or the point where the bile ducts emerge from the li...
Common Lifestyle Habits that Cause Diseases
Cigarette smoking, unhealthy diets, overuse of alcohol, and physical inactivity are some of the most...
Health Benefits of Dandelion Plant
What is dandelion? Dandelion greens are nutrition powerhouses with a wide range of health benefits. ...
Immune Checkpoint Inhibitors for Cancer Treatment
Immune checkpoint inhibitors are promising drugs to treat a variety of cancers and the FDA has appro...
Non-Communicable Diseases
Non-Communicable Diseases (NCDs) are a group of chronic non-infectious diseases which include Cardio...
Patent Ductus Arteriosus
Patent Ductus Arteriosus is a congenital defect of the heart where the fetal passage between pulmona...
Sclerosing Cholangitis
Sclerosing cholangitis is a liver disease characterized by inflammation and scarring of bile ducts w...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use